Decoding Health Podcast

We all want better medications. But who should pay for the years of research it takes to create them? 💊

Medical innovation does not happen for free.

Before a new drug reaches patients, a company may spend years funding research, testing compounds, navigating regulations, and absorbing the cost of failed programs.

Patent protection gives that company a limited period to defend its invention and recover its investment.

That system helps fund innovation.

But it also creates tension when demand is high, prices are controversial, and patients struggle to gain access.

That is why the GLP-1 debate is much more complicated than “expensive brand-name drug versus cheaper alternative.”

It is a battle involving:

⚖️ Patent rights
🔬 Scientific discovery
💰 Development costs
🌍 Patient access
📈 Market demand

Remove patent protection, and companies may be less willing to fund risky research.

Limit access too heavily, and lifesaving innovation can feel unavailable to the people it was designed to help.

What matters more: protecting the companies that fund innovation or making breakthrough medications more accessible?

Share your thoughts in the comments.

👉 Follow for more honest conversations about the science and business shaping your healthcare.

🎥 Watch the full episode on Rumble.
🔗 in the first comment.

Proudly supported by our strategic partner Unicity International and our sponsors IMeIMetabolic Biopharma Corporationd UK BioScience Consulting, LLC.

Thank you to our producers at PS PS Creative & PS Studios

💉 What if the future of GLP-1 medications is decided less by doctors—and more by lawyers, patents, and billion-dollar business interests?

Most people know semaglutide and tirzepatide as medications used for diabetes and weight management.

But these drugs are also proprietary molecules protected by powerful patents.

And those patents can help determine:

🔒 Who is legally allowed to make them
💰 How much patients may have to pay
🧪 Whether compounded versions can continue to exist
📦 How the medications are distributed
📈 Who controls one of the largest healthcare markets in the world

This is where the debate gets uncomfortable.

Drug development is expensive. Companies need intellectual-property protection to justify years of research, clinical trials, regulatory work, and financial risk.

But what happens when demand explodes, prices remain high, shortages occur, and millions of people want access?

This is not simply a debate between brand-name drugs and cheaper alternatives.

It is a battle involving innovation, profits, regulation, affordability, and patient access.

And the outcome could affect far more than the price of a prescription.

Do you believe pharmaceutical patents protect innovation—or can they sometimes create barriers between patients and treatment?

Share your perspective below. 👇

🎥 Watch the full conversation on Rumble.
🔗 Link in the first comment.

👉 Follow me for honest, evidence-based conversations that go beyond the headlines and expose the science, business, and incentives shaping your healthcare.

🙏 Special thanks to our sponsors, IMetabolic Biopharma Corporation and UK BioScience Consulting, LLC, and our producers at PS Creative & PS Studios.

🚨 GLP-1 drugs aren’t magic. They’re medicine.

And medicine has to be used responsibly.

GLP-1 drugs were created to solve a real problem.

For many people, they can be life-changing when used properly and under medical supervision.

But when demand explodes…
the money gets big.
the shortcuts get louder.
and the nuance gets lost.

This is not about attacking GLP-1 drugs.

It’s about asking:

Are we treating the root problem… or just chasing the fastest result?

Because sustainable health still requires:

💪 Muscle preservation
🥩 Better nutrition
🚶 Movement
🧠 Behavior change
🔥 Metabolic repair
❤️ Long-term support

Weight loss is not the finish line.

Health is.

In this conversation with Chris Powell, we break down the promise, the risk, and the line between responsible innovation and misuse.

💬 What do you think — are GLP-1 drugs being used responsibly?

👉 Follow for more real talk on metabolic health.
🎥 Watch the full episode on Rumble — 🔗 in First Comment.

Proud strategic partner: Unicity International Unicity
Sponsored by: iMBP iMetabolic Biopharma and UK BioScience Consulting, LLC
Produced by: PS Creative Studios PS Creative + PS Studios | AZ’S #1 PODCAST & CREATIVE AGENCY

🚨 Men are not silent because they feel nothing.

They are silent because many were taught that pain should be hidden.

Trauma should be buried.

Struggle should be handled alone.

And “I’m fine” should be enough.

But when one man finally opens up, something powerful happens.

The room changes.

The mask drops.

Other men realize they are not broken.

They are not weak.

They are not alone.

Vulnerability becomes contagious in the best way.

Healing does not happen in isolation.

Sometimes it begins when one person is brave enough to tell the truth.

This Decoding Health conversation with Chris Powell is about trauma, community, men’s mental health, and why sharing your story can change everything.

💬 Question: What would change if more men felt safe enough to speak honestly?

📺 Watch the full episode on Rumble
🔗 Link in First Comment

Follow for more conversations on health, healing, purpose, and human performance.

Proud to acknowledge our strategic partner Unicity International.

Special thanks to our sponsors iMBP iMetabolic Biopharma and UK BioScience Consulting, LLC.

Thank you to our producers at PS Creative Studios PS Creative + PS Studios | AZ’S #1 PODCAST & CREATIVE AGENCY .

🚨 The goal is not just to live longer.

The goal is to live better.
Too often, health conversations start only after something goes wrong.

What medication can help?
What therapy can help?
What intervention can help?

Those questions matter.
But they are not the whole story.

The bigger question is:
What habits, relationships, behaviors, and lifestyle choices are helping you build the highest quality of life possible?

Because lasting health is not built by medicine alone.

It is built through daily choices that support your body, your mind, your purpose, and your future.

Modern medicine can be incredibly powerful.
But real health optimization happens when science meets action.

Better sleep.
Better nutrition.
Better movement.
Better metabolic health.
Better relationships.
Better purpose.

That is how we do more than add years to life.
That is how we add life to those years.

In this conversation, Chris Powell and I talk about longevity, purpose, preventive health, and what it truly means to optimize your health.
What does “living better” mean to you?

🎙 Watch the full episode on Rumble.
🔗 in first comment

Follow for more conversations on metabolic health, longevity, and health optimization.

Proud to acknowledge our strategic partner Unicity International.

Thank you to our sponsors IMetabolic Biopharma Corporation and UK BioScience Consulting, LLC.

Special thanks to our producers at PS Creative & PS Studios.

The business of healthcare impacts your ability to care for your health.

breaks down how an all natural approach to reducing insulin resistance and increasing satiety, developed by the University of Sydney, is a little known commodity.

Why?
It’s the business of healthcare.

Who suffers?
The patients who need it most.

What is this all natural approach?
Drop me a comment and I will share.

🚨Weight loss is not always a food problem.

For many people, the struggle runs much deeper.

It can be tied to trauma.
Emotional pain.
Stress.
Grief.
Shame.
And coping patterns that started years before the physical weight ever showed up.

That is why telling someone to “just eat less and move more” can completely miss the real issue.

Food may have become comfort.
Protection.
Control.
Numbing.
A way to survive.

In this conversation, Chris Powell and I talk about the emotional side of weight loss and why sustainable transformation has to include more than calories and workouts.

When deeper wounds come to the surface, the right support matters.

Coaches can help with habits.
Clinicians can help with health.
But mental health professionals may be essential when trauma and emotional pain are part of the story.

Because true transformation is not just about changing the body.

It is about finally allowing the emotional story to be part of the healing process.

Question: Have you ever seen someone struggle with weight loss because the deeper emotional piece was never addressed?

Follow for more conversations on metabolic health, weight loss science, and true healing.

🎥 Watch the full episode on Rumble.
🔗 in first comment.

Proudly acknowledging our strategic partner: Unicity International

Special thanks to our sponsors: IMetabolic Biopharma Corporation and UK BioScience Consulting, LLC

Thank you to our producers at PS Creative & PS Studios

🚨 You can under-eat your way into failure.

This may sound controversial, but more restriction is not always the answer.

Especially when someone is carrying significant weight and already performing hours of physical activity every day.

At that point, severely cutting calories may not create better results.

It may create more stress, slower recovery, muscle loss, fatigue, cravings, and eventually burnout.

Real transformation requires more than punishment.

It requires enough fuel to support:

✅ Movement
✅ Recovery
✅ Muscle
✅ Energy
✅ Hormonal balance
✅ Long-term consistency

The goal is not to starve the body into change.

The goal is to build a strategy that creates progress without destroying the person in the process.

In this conversation with Chris Powell, we discuss nutrition, performance, sustainable weight loss, and why proper fueling matters far more than most people realize.

💬 Question: Have you ever tried eating less and exercising more, only to feel worse instead of better?

Follow for more real-world conversations on metabolic health, sustainable fat loss, nutrition, and lasting transformation.

Watch the full episode on Rumble. 🔗 in first comment.

Proud to acknowledge our strategic partner Unicity International.

Special thanks to our sponsors IMetabolic Biopharma Corporation and UK BioScience Consulting, LLC.

Thank you to our producers at PS Creative & PS Studios.